Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a new revision label: v3.5.4, replacing the previous v3.5.3 in the document revision list. This indicates an updated version of the study-related documents has been published.SummaryDifference0.0%

- Check19 days agoChange DetectedLocation list updated: Taoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333, and a new Taoyuan, Taiwan site (333) was added.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page shows a new revision tag of v3.5.3 replacing the previous v3.5.2, signaling a newer release of the page. This typically reflects minor release updates rather than substantive changes to the study data.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version upgrade with no visible impact on study details.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.